|
|
|||||||||
Basic Science Investigation |
1 Center for Cardiovascular Targeting, School of Pharmacy, Bouve College of Health Sciences, Northeastern University, Boston, Massachusetts; and 2 Division of Cardiology, Department of Medicine, Columbia University Medical Center, New York, New York
Correspondence: For correspondence or reprints contact: Ban-An Khaw, PhD, Center for Cardiovascular Targeting, School of Pharmacy, Bouve College of Health Sciences, Northeastern University, Boston, MA 02115 E-mail: b.khaw{at}neu.edu
In vivo molecular imaging may be improved if specific radioactivity at the target site could be increased while maintaining low background activity. Bispecific antibody complexes and 99mTc-labeled negatively charged chelating polymers that react specifically with the capture arm of the bispecific antibody complex were used to demonstrate the feasibility of imaging very small atherosclerotic lesions in ApoE knockout mice. Methods: Left femoral artery denudation in ApoE/ mice on a hyperlipidemic diet was used to induce accelerated atherosclerotic lesions. Approximately 40 µg of bispecific antibodies were injected intravenously after 2 wk of endothelial denudation. The next day,
15.0 MBq 99mTc-DTPAsuccinyl-polylysine (2 µg; DTPA is diethylenetriaminepentaacetic acid) were injected intravenously. Results: In vivo
-images showed that lesions were observed unequivocally by 23 h. Sham-operated right femoral regions showed no radiotracer accumulation. Ex vivo
-scintillation counting corrected for sham-operated nonspecific activity and lesion mass showed that the mean lesion activity was 10.10 ± 6.76 %ID/g (percentage injected dose per gram), whereas nonspecific human IgG bispecific control (NSB control) also corrected similarly was 0.939 ± 0.877 %ID/g (P < 0.03). Atherosclerotic lesions were confirmed by immunohistochemical staining. Computer planimetry of immunohistograms showed the mean lesion size to be 2.64 ± 2.46 mg. Conclusion: Use of bispecific antibody complexes and 99mTc-DTPAsuccinyl-polylysine enabled in vivo visualization of very small atherosclerotic lesions in ApoE knockout mice.
Key Words: bispecific antibody pretargeting radiolabeled polymer
This article has been cited by other articles:
![]() |
J. Zhang, L. Nie, M. Razavian, M. Ahmed, L. W. Dobrucki, A. Asadi, D. S. Edwards, M. Azure, A. J. Sinusas, and M. M. Sadeghi Molecular Imaging of Activated Matrix Metalloproteinases in Vascular Remodeling Circulation, November 4, 2008; 118(19): 1953 - 1960. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Tekabe, Q. Li, R. Rosario, M. Sedlar, S. Majewski, B. I. Hudson, A. J. Einstein, A. M. Schmidt, and L. L. Johnson Development of Receptor for Advanced Glycation End Products-Directed Imaging of Atherosclerotic Plaque in a Murine Model of Spontaneous Atherosclerosis Circ Cardiovasc Imaging, November 1, 2008; 1(3): 212 - 219. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. L. Franc, P. D. Acton, C. Mari, and B. H. Hasegawa Small-Animal SPECT and SPECT/CT: Important Tools for Preclinical Investigation J. Nucl. Med., October 1, 2008; 49(10): 1651 - 1663. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | RSS | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |